Damien JOLLY
Reims, France
NCT Number: NCT03623191
Erosive pustular dermatosis of the leg is a fairlyrecent clinical entity that was described the first time in 1987.
Diagnosis of erosive pustular dermatosis of the leg is made on clinical grounds. It presents as non-follicular pustules of variable size and numbers that rapidly give way to erosions and crusts on one or both legs, and which are found in particular on the anterior aspect of the middle third of the leg (. The lesions are of chronic progression, despite topical therapy. Erosive pustular dermatosis of the leg is seen in elderly patients, mainly female, and may be associated with chronic venous insufficiency or cutaneous atrophy. In the absence of specific criteria and because of the existence of misleading clinical forms, diagnosis is based upon exclusion.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Reims, France
The primary objective of this investigation was to describe the different clinical aspects of cases of Erosive pustular dermatosis of the leg.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day 0
Anterior or posterior leg face
Time frame: Day 0
Less than 10 erosions, between 10 and 50 erosions and more than 50 erosions
Time frame: Day 0
Diagnosis based on the CEAP 2004 Score (Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, GloviczkiP, Kistner RL, et al. Revision of the CEAP classification forchronic venous disorders: consensus statement. J Vasc Surg2004;40:1248-52)
CHU de Reims
Other
Acronym: Clin-EPDL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07699796
Cardiovascular Diseases, Embolism and Thrombosis
Fresno, California, United States
View Trial DetailsNCT07616115
Cardiovascular Diseases, Saphenous Vein
São Paulo, Brazil
View Trial DetailsNCT06438133
Cardiovascular Diseases, Compression; Vein
Bispebjerg, Capital Region, Denmark
View Trial DetailsNCT02061254
Cardiovascular Diseases, Fibrosis
Tours, France
View Trial Details